APA (7th ed.) Citation

Gauthier, J., Bezerra, E. D., Hirayama, A. V., Fiorenza, S., Sheih, A., Chou, C. K., . . . Turtle, C. J. (2021). Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignancies. Blood, 137(3), 323. https://doi.org/10.1182/blood.2020006770

Chicago Style (17th ed.) Citation

Gauthier, Jordan, et al. "Factors Associated with Outcomes After a Second CD19-targeted CAR T-cell Infusion for Refractory B-cell Malignancies." Blood 137, no. 3 (2021): 323. https://doi.org/10.1182/blood.2020006770.

MLA (9th ed.) Citation

Gauthier, Jordan, et al. "Factors Associated with Outcomes After a Second CD19-targeted CAR T-cell Infusion for Refractory B-cell Malignancies." Blood, vol. 137, no. 3, 2021, p. 323, https://doi.org/10.1182/blood.2020006770.